gvtcx

NHS National Pharmaceuticals Transition 2019_2

NHS England Published 24 Sept 2019 Contracts Finder

key details

Value£40,411,733
Statuscomplete
Category (CPV) 33600000 +1 more
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline28 Oct 2019
Contract start1 Feb 2020
Contract end31 Oct 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-8f7d0b8e-0fae-4975-853b-d4fe5dfdaa6f

Award

SupplierValueDateStatus
Please see list of awarded suppliers (including SME status) at t £80,823,466 28 Nov 2019 active

description

NHS National Pharmaceuticals Transition 2019_2

Offer reference number: CM/PHG/17/5548 Period of framework agreement: The total maximum duration of the framework agreement to be no more than

  1. months

Potential periods of call-offs under the framework agreement:

NWLN: 01/02/2020 to 30/09/2020 (8 months)

LSNE: 01/02/2020 to 28/02/2021 (13 months)

CESW: 01/02/2020 to 31/10/2021 (21 months)

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
6 Mar 2020 Award (award) · 19353546-f4c9-405c-a477-be5a1bac12ed-348306

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.